S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q4 2025

Deep Track Capital

Period: Q4 2025 Β· Filed: 2026-02-13
View on SEC EDGAR β†—
AUM
$5.61B
Total portfolio value
Positions
55
Reported securities
Top Holding
XBI
21.7% $1.22B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-02-13) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
XBIPUTSPDR SERIES TRUST$1.22B21.74%$121.81$160.46+31.7%
21.7%
IMVTIMMUNOVANT INC$293.0M5.22%$25.42$38.79+52.6%
5.2%
GHGUARDANT HEALTH INC$286.0M5.10%$102.14$167.98+64.5%
5.1%
GPCRSTRUCTURE THERAPEUTICS INC$286.0M5.10%$69.55$53.45-23.1%
5.1%
TARSTARSUS PHARMACEUTICALS INC$246.0M4.39%$81.88$65.44-20.1%
4.4%
DVAXDYNAVAX TECHNOLOGIES CORP$241.9M4.31%β€”β€”
4.3%
CYTKCYTOKINETICS INC$212.0M3.78%$63.54$86.49+36.1%
3.8%
AXSMAXSOME THERAPEUTICS INC$210.0M3.74%$182.64$244.31+33.8%
3.7%
APLSAPELLIS PHARMACEUTICALS INC$194.7M3.47%$25.12β€”
3.5%
PCVXVAXCYTE INC$184.6M3.29%$46.14$58.39+26.6%
3.3%
MAZEMAZE THERAPEUTICS INC$175.9M3.14%$41.43$31.26-24.6%
3.1%
VERAVERA THERAPEUTICS INC$142.9M2.55%$50.64$41.20-18.6%
2.5%
BMRNBIOMARIN PHARMACEUTICAL INC$136.7M2.44%$59.43$58.99-0.7%
2.4%
IONSIONIS PHARMACEUTICALS INC$134.5M2.40%$79.11$81.80+3.4%
2.4%
NRIXNURIX THERAPEUTICS INC$133.5M2.38%$18.97$23.97+26.4%
2.4%
MBXMBX BIOSCIENCES INC$102.5M1.83%$31.54$57.80+83.3%
1.8%
OCULOCULAR THERAPEUTIX INC$98.0M1.75%$12.14$9.64-20.6%
1.8%
GRALGRAIL INC$87.5M1.56%$85.59$69.11-19.3%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$78.6M1.40%$31.12$19.40-37.7%
1.4%
LBRXLB PHARMACEUTICALS INC$74.6M1.33%$22.26$33.43+50.2%
1.3%
IMCRIMMUNOCORE HLDGS PLC$69.6M1.24%$34.71$32.50-6.4%
1.2%
ORKAORUKA THERAPEUTICS INC$65.5M1.17%$30.31$85.21+181.1%
1.2%
BBIOBRIDGEBIO PHARMA INC$62.0M1.10%$76.49$77.19+0.9%
1.1%
CRMDCORMEDIX INC$61.3M1.09%$11.63$8.75-24.8%
1.1%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$60.8M1.08%$13.18$18.95+43.8%
1.1%
ALKSALKERMES PLC$56.0M1.00%$27.98$54.58+95.1%
1.0%
DYNDYNE THERAPEUTICS INC$51.8M0.92%$19.56$23.07+17.9%
0.9%
CLDXCELLDEX THERAPEUTICS INC NEW$51.6M0.92%$27.16$38.37+41.3%
0.9%
CMPSCOMPASS PATHWAYS PLC$50.6M0.90%$6.90$13.62+97.4%
0.9%
CNTACENTESSA PHARMACEUTICALS PLC$50.0M0.89%$25.01$40.50+61.9%
0.9%

Quarter-on-Quarter Activity

Q4 2025 vs. Q3 2025

New Positions (8)

TickerIssuerNotionalSince Filing
XBIPUTSPDR SERIES TRUST$1.22B+31.7%
VERAVERA THERAPEUTICS INC$142.9M-18.6%
GRALGRAIL INC$87.5M-19.3%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$60.8M+43.8%
ALKSALKERMES PLC$56.0M+95.1%
CNTACENTESSA PHARMACEUTICALS PLC$50.0M+61.9%
SLNOSOLENO THERAPEUTICS INC$46.3M
VSTMVERASTEM INC$44.3M

Exited Positions (8)

TickerIssuerNotional
AKROAKERO THERAPEUTICS INC$190.0M
ETNB89BIO INC$137.5M
PTGXPROTAGONIST THERAPEUTICS INC$114.0M
EXASEXACT SCIENCES CORP$54.7M
OLMAOLEMA PHARMACEUTICALS INC$34.0M
CDTXCIDARA THERAPEUTICS INC$28.7M
QUREUNIQURE NV$28.2M
JBIOJADE BIOSCIENCES INC$19.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
BMRNBIOMARIN PHARMACEUTICAL INC$135.3M+9153.3%-0.7%
CRMDCORMEDIX INC$55.5M+954.8%-24.8%
XFORX4 PHARMACEUTICALS INC$16.2M+346.7%
ENGNENGENE HOLDINGS INC$24.2M+95.5%
HELPCYBIN INC$9.3M+85.4%
TNGXTANGO THERAPEUTICS INC$9.5M+68.7%
PCVXVAXCYTE INC$76.5M+33.3%+26.6%
DYNDYNE THERAPEUTICS INC$26.5M+32.5%+17.9%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
TERNTERNS PHARMACEUTICALS INC$-25.2M-89.7%
RAPTRAPT THERAPEUTICS INC$-15.6M-85.3%
XENEXENON PHARMACEUTICALS INC$-31.8M-69.5%
IONSIONIS PHARMACEUTICALS INC$-114.6M-55.4%+3.4%
VRDNVIRIDIAN THERAPEUTICS INC$-37.5M-53.1%-37.7%
GHGUARDANT HEALTH INC$26.4M-32.6%+64.5%
BBIOBRIDGEBIO PHARMA INC$-0.4M-32.5%+0.9%
OCULOCULAR THERAPEUTIX INC$-41.5M-32.4%-20.6%
← Back to Hedge Funds